Newborn bloodspot screening resources

The document summarises the outcomes of conditions identified through the pre-assessment process for Australia's Newborn Bloodspot Screening program. It displays this information as a table with condition name and the outcome of that condition.

This fact sheet outlines the key steps and timeframes for adding new conditions to NBS programs to support the safe and consistent expansion of NBS in Australia.

This publication presents a summary of the work undertaken to examine the ethical considerations and social acceptability of screening X-linked adrenoleukodystrophy (X-ALD) in female newborns.

This fact sheet provides information on the national NBS decision-making pathway, including the role of each committee in the process.

This fact sheet provides information about what NBS expansion means for families and consumers, expansion progress to date, and upcoming milestones.

This publication outlines the key findings of the national readiness assessment conducted in 2023. The aim of the readiness assessment is to understand how NBS programs operate nationally. It also looks at critical factors for achieving consistency and expanding the number of conditions screened.

This publication outlines the key findings from our public consultation on the expansion of newborn bloodspot screening programs.

This report gives an overview of the public consultation process that we undertook for the expansion of newborn bloodspot screening programs.

Tasmanian Health Service information brochure explaining how newborn bloodspot screening works in Tasmania.

South Australia Pathology brochure explaining how newborn bloodspot screening works in South Australia.

The Newborn Bloodspot Screening National Policy Framework guides the national policies needed to support the ongoing success of newborn bloodspot screening in Australia.